CD8A and Hand-foot syndrome: Our findings predict that treatment regimens which promote an immuno-inhibitory phenotype and/or suppress the switch towards a pro-inflammatory MC phenotype, should down-regulate undesired CD8+ T-cell responses against human HFs.